advanced therapies international congress

 

 

 

 

 

 

 

ISSCA will sponsor the 6th annual International Congress on Advanced Therapies in Medicine Nov. 24-25, 2018 in Riviera Nayarit.

MIAMI, July 27, 2018—For the third consecutive year the International Association for Stem Cell Application (ISSCA) will sponsor the International Congress on Advanced Therapies in Medicine 2018 on Puerto Vallarta, Mexico.

The event will feature a commercial expo with 20 with 20 booths exhibiting new products and information for physicians in the field of regenerative medicine. More than 250 physicians are expected to be in attendance.

ISSCA will present information on its Fellowship in Cell Therapy and Tissue Engineering program, a 6-day course during which a group of experienced academicians involved in stem cell transplantation present the general principles and practice of stem cell biology and evidence-based treatments to physicians looking to optimize the treatment options that benefit the health of their patients. The fellowship program will be held in Korea Oct. 22-27, 2018.

Fellowship participants will take part in a detailed program offering hands-on experience in stem cell applications and learn cell culture protocols including plating, trypsinization, harvesting, and cryopreservation, as well as an understanding and application of quality control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma and sterility.

In addition, physicians participating in the ISSCA fellowship program will learn how to perform cGMP functions including cleanroom maintenance, gowning and environmental monitoring, while gaining insight on relevant applications of stem cell processing and regulations in a certified facility. ISSCA provides fellowship attendees with the tools necessary to implement regulatory and clinical guidelines when setting up a GMP facility, as well as copies of presentations, procedural protocols and all forms associated with a GMP facility provided.

Participating physicians learn to perform clinical procedures including lipoaspirate and bone marrow isolation, and reintroducing stem cells for various indications. Case books and full protocols for approximately 30 indications are also provided.

In addition, Global Stem Cells Group )GSCG) will present its stem cell processing center, a complete solution for providers to equip their practice facilities with an on-site regenerative medicine lab. Used for tissue processing, isolation, culturing and cryopreservation of stem cells, the stem cell processing center is designed to execute a state-of-the-art stem cell laboratory using the latest technology.

GSCG provides participating regenerative medicine teams with specialized training to implement high-level processes and therapies using the stem cell processing center for better clinical interpretation, better results while maintaining compliance with safety regulations and international standards.

GSCG’s stem cell laboratory solution represents a tremendous competitive advantage and differentiator that arms regenerative medicine practitioners with the ability to perform highly advanced stem cell procedures in their facilities.

The 2018 International Congress on Advanced Therapies in Medicine in Riviera Nayarit, Mexico will be held at the Hotel Krystal Grand in Nuevo Puerto Vallarta,

For more information and to register, email  info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine.

ISSCA serves its members through advancements made in the specialty of regenerative medicine.ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stopepicenter for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

advanced therapies international congress